Atlas Trials

A Study to Assess Safety and Efficacy of a Novel Patch Infusor Device and Novel SUBCUTaneous Furosemide Formulation Combination in Patients With Heart Failure

Clinical trial NCT04846816 · COMPLETED

Trial details

NCT number
NCT04846816
Sponsor
SQ Innovation, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Heart Failure
Start date
2021-05-06
Primary completion
2021-08-13
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.